FDA Is Now Tracking Adverse Health Events Related To Hemp Cannabinoids Like CBD Following White House Approval – Marijuana Moment
The Food and Drug Administration (FDA) has updated its adverse drug event reporting forms to begin tracking incidents related to hemp-derived cannabinoid products such as CBD.
The change to the fede…